Verzeichnis der wissenschaftlichen Arbeiten von Martina Mittlböck
(Publications list of Martina Mittlböck)


to appear

  1. Riss S., Bittermann C., Zandl S., Kristo I., Stift A., Papay P., Vogelsang H., Mittlböck M. and Herbst F.: Short Term Complications of Wide-Lumen Stapled Anastomosis after Ileocolic Resection for Crohn´s Disease - Who is at risk? Colorectal Disease; to appear.

    2009
  2. Edler L., Lee J.W., Mittlböck M., Niland J. and Victor N. (2009): Editorial "Computational statistics within clinical research. Computational Statistics & Data Analysis; Vol. 53, 583-585.
  3. Fleischhackl R., Nürnberger A., Sterz F., Schönberg C., Urso T., Habart T., Mittlböck M. and Chandra-Strobos N.: School children sufficiently apply life supporting first aid: a prospective investigation. Critical Care 2009; Vol. 13(4), R127, 7 pages
  4. Jakesz R., Gnant M., Greil R., Tausch C., Samonigg H., Kwasny W., Kubsita E., Stierer M., Luschin G., Rücklinger E., and Mittlböck M. (2009): Tamoxifen and anastrozole as a sequencing strategy in postmenopausal women with hormone-responsive early breast cancer: updated data from the Austrian breast and colorectal cancer study group trial 8. Cancer Research, Vol. 69, 67S.
  5. Mailath-Pokorny M., Preyer O., Dadak C., Lischka A., Mittlböck M., Wagenbichler P. and Laml T. (2009): Breech presentation: A retrospective analysis of 12-years' experience at a single center. Wiener Klinische Wochenschrift; Vol. 121, 209-215.

  6. Michaelidou M., Tzou C.-H., Gerber H., Stüssi E., Mittlböck M. and Frey M. (2009): The Combination of Muscle Transpositions and Static Procedures - A Useful Concept for Reconstruction in the Paralyzed Face of the Patient with Limited Life Expectancy or Who is not a Candidate for Free Muscle Transfer. Plastic and Reconstructive Surgery; Vol. 123, 121-129.
  7. Mittlböck M. und Hanzal E. (2009): Editorial: "Zahlen lesen". krebs:hilfe!; Heft 2:2009, III.
  8. Mittlböck M. (2009): Einführung in das statistische Testen. krebs:hilfe!; Heft 2:2009, VI-VIII.

  9. Nagele P., Zeugswetter B., Eberle C., Hüpfl M., Mittlböck M. and Födinger M.: A common gene variant in methionine synthase reductase is not associated with peak homocysteine concentrations after nitrous oxide anesthesia. Pharmacogenetics and Genomics; Vol. 19, 325-329.
  10. Riedl O., Fitzal F., Mader N., Dubsky P., Rudas M., Mittlböck M., Gnant M. and Jakesz R. (2009): Intraoperative frozen section analyses for breast conserving therapy in 1016 patients with breast cancer. European Journal of Surgical Oncology; Vol. 35, 264-270.
  11. Riss S., Stift A., Teleky B., Rieder E., Mittlböck M., Maier A. and Herbst F. (2009): Long-term anorectal and sexual function after overlapping anterior anal sphincter repair: a case-match study. Diseases of the Colon & Rectum; Vol. 52, 1095-1100.
  12. Riss S., Akan B., Rieder E., Karner-Hanusch J., Dirlea D., Mittlböck M. and Weiser F.A.: CO2 insufflation during colonoscopy decreases post-interventional pain in deep sedated patients: "A randomized controlled trial" (RCT). Wiener Klinische Wochenschrift; Vol. 121, 464-468.
  13. Rössler B., Fleischhackl R., Losert H., Arrich J., Mittlböck M., Domanovits H. and Hörauf K. (2009): Reduced hands-off-time and time to first shock in CPR according to the ERC Guidelines 2005. Resuscitation; Vol. 80, 104-108.
  14. Rössler B., Fleischhackl R., Losert H., Wallander C., Arrich J., Mittlböck M., Domanovits H. and Hörauf K. (2009): Cardiopulmonary resuscitation and the 2005 universal algorithm: Has quality of CPR improved? Wiener Klinische Wochenschrift; Vol. 121, 41-46.

    2008
  15. Bühl W., Heinzl H., Mittlböck M. and Findl O. (2008): Statistical problems caused by mising data resulting from neodymium: YAG laser capsulotomies in long-term posterior capsule opacification studies: problems identification and possible solutions. Journal of Cataract and Refractive Surgery; Vol. 34, 268-273.
  16. Fitzal F., Mittlböck M., Trischler H., Krois W., Nehrer G., Deutinger M., Jakesz R. and Gnant M. (2008): Breast Conserving Therapy for Centrally Located Breast Cancer. Annals of Surgery; Vol. 247, 470-476.
  17. Fleischhackl R., Rössler B., Domanovits H., Singer F., Fleischhackl S., Foitik G., Czech G., Mittlböck M., Malzer R., Eisenburger P. and Hörauf K. (2008): Results from Austria's Nationwide Public Access Defibrillation (ANPAD) Programme collected over 2 years. Resuscitation; Vol. 77, 195-200.

  18. Frey M., Michaelidou M., Tzou C.-H., Pona I., Mittlböck M., Gerber H. and Stüssi E. (2008): Three-Dimensional Video Analysis of the Paralyzed Face Reanimated by Cross-Face Nerve Grafting and Free Gracilis Muscle Transplantation: Quantification of the Functional Outcome. Plastic and Reconstructive Surgery; Vol. 122, 1709-1722.
  19. Gnant M., Mlineritsch B., Luschin-Ebengreuth G., Kainberger F., Kässmann H., Piswanger-Sölkner J., Seifert M., Ploner F., Menzel C., Dubsky P., Fitzal F., Bjelic-Radisic V., Steger G., Greil R., Marth C., Kubista E., Samonigg H., Wohlmuth P., Mittlböck M. and Jakesz R. on behalf of the Austrian Breast and Colorectal Cancer Study Group (ABCSG): Adjuvant Endocrine Therapy Plus Zoledronic Acid in Premenopausal Women With Early Breast Cancer: 5-Year Follow-up of the ABCSG-12 BMD Substudy. Lancet Oncology; Vol. 9, 840-849.
  20. Heinzl H., Mittlböck M. and Edler L. (2008): Technical uncertainty in the backcalculation of occupational exposure to dioxins. Statistics in Medicine; Vol. 27, 2214-2233.

  21. Jakesz R., Gnant M., Greil R., Tausch C., Samonigg H., Kwasny W., Kubista E., Stierer M., Luschin G. and Mittlböck M. (2008): Tamoxifen and anastrozole as a sequencing strategy in postmenopausal women with hormone-responsive early breast cancer: updated data from the Austrian breast and colorectal cancer study group trial 8. San Antonio Breast Cancer Symposium (SABCS), December 10-14, 2008.

  22. Kandioler D., Stamatis G., Eberhardt W., Kappel S., Zöchbauer-Müller S., Kührer I., Mittlböck M., Zwrtek R., Aigner C., Bichler Ch., Tichy V., Hudec M., Bachleitner T., End A., Müller M., Roth E. and Klepetko W. (2008): Growing clinical evidence for the interaction of the p53 genotype and response to induction chemotherapy in advanced NSCLC. The Journal of Thoracic and Cardiovascular Surgery; Vol. 135, 1036-1041.
  23. Kappel S., Bichler C., Wolf, B., Gacic S., Schoppmann S.F., Devyatko Y., Prager G., Ba-SSalamah A., Wrba F., Pluschnig U., Kührer I., Mittlböck M., Hejna M., Zacherl J., Kandioler D., for the Pancho Study Group (2008): Turning the tables on surgical oncology: the ●Pancho trial unplugged. European Surgery. Vol. 40, 277-283.
  24. Mailath-Pokorny M., Preyer O., Dadak C., Lischka A., Mittlböck M., Wagenbichler P. and Laml T. (2008): The breech presentation birth-results of a single centre after 12-year experiecne. Geburtshilfe und Frauenheilkunde. Vol. 68, 422-422.
  25. Mittlböck M. (2008): Critical Appraisal of randomized clinical trials: Can we have faith in the conclusions? Breast Care; Vol. 3, 341-346.
  26. Mittlböck M. and Heinzl H. (2008): Measuring Heterogeneity in Meta-Analyses. LIFESTAT 2008 - First Conference of the Central European Network, Munich, Germany, 10.-13. 3. 2008.
  27. Nagele P., Zeugswetter B., Wiener C., Burger H., Hüpfl M., Mittlböck M. and Födinger M.: Influence of MTHFR Gene Polymorphisms on Homocysteine Concentrations after Nitrous Oxide Anesthesia. Anesthesiology; Vol. 109, 36-43 (with Editorial View, Anaesthesiology, Vol. 109, 5-6).
  28. Roka F., Mastan P., Binder M., Okamoto I., Mittlböck M., Horvat R., Pehamberger H. and Diem E. (2008): Prediction of non-sentinel node status and outcome in sentinel node-positive melanoma patients. European Journal of Surgical Oncology; Vol. 34, 82-88.

    2007

  29. Crismani A., Celar A., Burstone C., Bernhart T., Bantleon H., Mittlböck M. (2007): Sagittal and vertical load-deflection and permanent deformation of transpalatal arches connected with palatal implants: An in vitro study. American Journal of Orthodontics & Dentofacial Orthopedics, Vol. 131, 742-752.
  30. Fitzal F., Nehrer G., Riedl, G. , Dubsky P., Bachleitner T., Sporn E., Mittlböck M., Jakesz R. and Gnant M. (2007): Improving cosmetic outcome in central breast cancer: The use of oncoplastic techniques. The Breast, Vol. 16, S34.

  31. Fleischhackl R., Nuemberger A., Schönberg C., Urso T., Habart T. and Mittlböck M. (2007): Can schoolchildren provide life supporting first aid sufficiently? Vol. 116, 927-927.

  32. Gnant M., Mlineritsch B., Luschin-Ebengreuth G., Grampp S., Kaessmann H., Schmid M., Menzel C., Piswanger-Soelkner J., Galid A., Mittlböck M., Hausmanninger H. and Jakesz R. (2007): Zoledronic Acid Effectively Prevents Cancer Treatment-Induced Bone Loss in Premenopausal Women Receiving Adjuvant Endocrine Therapy for Hormone-Responsive Breast Cancer: A Report from the Austrian Breast and Colorectal Cancer Study Group. Journal of Clinical Oncology, Vol. 25, 820-828.
  33. Heinzl H., Benner A., Ittrich C. and Mittlböck M. : Proposals for sample size calculation programs. Methods of Information in Medicine, Vol. 46, 655-661.
  34. Heinzl H., Mittlböck M. and Edler L. (2007): On the translation of uncertainty from toxicokinetic to toxicodynamic models - the TCDD example. Chemosphere, Vol. 67, S365-S374.
  35. Heinzl H., Mittlböck M. and Edler L. (2007): Uncertainty in the Estimation of Dose metrics for Dioxin Risk Assessment Estimation - Backcalculation of Occupational Exposure. ICSMRA International Conference on Statistics and Risk Analysis, 30.-31. August 2007, Book of Abstracs, 51-52.
  36. Heinzl H. and Mittlböck M. (2007): Eine Einführung zu chirurgischen Lernkurvenstudien aus Sicht der medizinischen Statistik und Dokumentation. MDI; Issue 1, 30-33.
  37. Heinzl H., Benner A., Ittrich C. and Mittlböck M. (2007): Der Typ-III-Fehler bei zweiarmigen Therapievergleichsstudien. Statistik 2007 - Statistik unter einem Dach, gemeinsame Tagung der Deutschen Arbeitsgemeinschaft Statistik und der Deutschen Statistischen Gesellschaft, Biometrisches Kolloquium, p137.

  38. Miholic J., Hoffmann M., Holst J., Lenglinger J., Mittlböck M., Bergmann H. and Stacher G. (2007): Gastric emptying of glucose solution and associated plasma concentrations of GLP-1, GIP, and PYY before and after fundoplication. Surgical Endoscopy and other interventional techniques, Vol. 21, 309-314.

  39. Mittlböck M., Gnant M., Greil R., Fridrik M. and Wohlmuth P. (2007): Evaluation of Surrogate Markers When Surrogate and True Endpoints Are Survival Times. 28th Meeting of the International Society of Clinical Biostatistics, Alexandroupolis, Greece, 29.7.-2.8.2007.
  40. Mittlböck M. and Heinzl H. (2007): Assessing Heterogeneity in Meta-Analyses. Seminar of the Austro-Swiss Region of the International Biometric Society, Bern, Switzerland, 10.-13. September 2007.
  41. Rössler B., Fleischhackl R., Fleischhackl S., Singer F., Mittlböck M., Fachberger J., Malzer R., Koller A., Lang G., Foitik G. and Hörauf K. (2007): Death in Correctional Facilities; Opportunities for Automated External Defibrillation. Resuscitation, Vol. 73, 389-393.
  42. Rössler B., Fleischhackl R., Losert H., Wandaller C., Arrich J., Mittlböck M., Domanovits H. and Hörauf K. (2007): Practical Impact of the ERC BLS Algorithm 2005. Resuscitation, Vol 74, 102-171.
  43. Strohal R., Speiser-Rankine N., Unterberger W., Taibl R., Payer-Neundlinger G. and Mittlböck M. (2007): Development and implementation of process-oriented skin saftey standards for the oil and gas industry - a pilot study. Allergologie, Vol. 30, 288-288.

    2006

  44. Draxler W. and Mittlböck M. (2006): Basic principles in the planning of clinical trials in surgical oncology: Grundlagen von Studienplanung in der chirurgischen Onkologie, European Surgery, Vol. 38, 27-32.

  45. Fitzal F., Sporn E., Draxler W., Mittlböck M., Taucher S., Rudas M., Riedl O., Helbich T., Jakesz R. and Gnant M. (2006): Preoperative core needle biopsy does not increase local recurrence rate in breast cancer patients. Breast Cancer Research and Treatment, Vol. 997, 9-15.

  46. Fitzal, F., Sporn, E., Draxler, W., Mittlböck, M., Taucher, S., Rudas, M., Riedl, O., Helbich, T., Jakesz, R., and Gnant, M. Preoperative core needle biopsy does not increase local recurrence rate in breast cancer patients. EJSO 32, Suppl.1, S92. 2006.

  47. Fleischhackl R., Foitik G., Czeck G., Rössler B., Mittlböck M., Domanovits H. and Hörauf K. (2006): Reaching the public via multi media campaign as a first step to nationwide public access defibrillation. Resuscitation, Vol. 69, 269-275.
  48. Fleischhackl R., Singer F., Nitsche W., Gamperl G., Rössler B., Arrich J., Fleischhackl S., Losert H., Sterz F., Mittlböck M. and Hörauf K. (2006): Influence of Electromagnetic Fields on Function of Automated External Defibrillators. Academic Emergency Medicine, Vol. 13, 1-6.
  49. Fleischhackl R., Singer F., Rössler B., Arrich J., Fleischhackl S., Losert H., Sterz F., Mittlböck M. and Hörauf K. (2006): In Saftey testing of automated external defibrillators with humans in electromagnetic fields and relevance for public access defibrillation - In reply. Academic Emergency Medicine, Vol. 13, 908-909.
  50. Fleischhackl R., Singer F., Rössler B., Arrich J., Fleischhackl S., Losert H., Uray T., Köhler K., Sterz F., Mittlböck M. and Hörauf K. (2006): Automated External Defibrillators Do Not Recommend False Positive Shocks Under the Influence of Electromagnetic Fields Present at Public Locations. Anesthesia & Analgesia, Vol. 103, 1485-1488.
  51. Fleischhackl R., Rössler B., Losert H., Wandaller C., Arrich J., Mittlböck M., Hörauf K., Domanovits H. and Sterz F. (2006): Resuscitation Guidelines 2005 Improve CPR Effectiveness Parameters. Resuscitation Science Symposium, Chicago, November 2006.
  52. Fleischhackl R., Singer R., Rössler B., Arrich J., Fleischhackl S., Losert H., Uray T., Köhler K., Mittlböck M., Sterz F. and Hörauf K. (2006): Influence of electro-magnetic fields present in locations suitable for public access defibrillation on ECG analysis of automated external defibrillators. 8th Scientific Congress of the European Resuscitation Council, 10-13 May 2006, Stavanger, Norway.

  53. Mittlböck M. and Heinzl H. (2006): A simulation study comparing properties of the heterogeneity measures in meta-analyses. Statistics in Medicine, Vol. 25, 4321-4333.
  54. Mittlböck M. (2006): Impact of the choice of disease- or event related outcomes in randomised clinical trials. ISCB 27, 27-31. August 2006, Geneva, Switzerland, p122.
  55. Mittlböck, M., Eigenbauer, E., and Heinzl, H. (2006): Lernkurven in der Chirurgie. 51.Jahrestagung der GMDS, 10.-14.September 2006, Leipzig, Deutschland, p157.
  56. Mittlböck, M. H. (2006): Statistical Aspects of experimental animal studies. ALTEX - Alternatives to animal experimentation, Vol. 23, 116.
  57. Rab M., Grünbeck M., Beck H., Haslik W., Schrögendorfer K., Schiefer H., Mittlböck M. and Frey M. (2006): Intra-individual comparison between openand 2-portal endoscopic release in clinically matched bilateral carpal syndrome. Journal of Plastic, Reconstructive & Aesthetic Surgery, Vol. 59, 730-736.
  58. Rössler B., Fleischhackl R., Losert H., Wandaller C., Arrich J., Mittlböck M., Domanovits H. and Hörauf K. (2006): Bystander Basic Life Support and the European Resuscitaiton Council Guidelines 2005. Circulation, Vo. 114(18), 1192.
  59. Rössler B., Fleischhackl R., Losert H., Wandaller C., Arrich J., Mittlböck M., Domanovits H. and Hörauf K. (2006): The more the better; Chest compressions and the ERC Guideline 2005 (2006): 8th Scientific Congress of the European Resuscitation Council, 10-13 May 2006, Stavanger, Norway.
  60. Rössler B., Fleischhackl R., Losert H., Wandaller C., Arrich J., Mittlböck M., Domanovits H. and Hörauf K. (2006): Bystander basic life support and the European Resuscitation Council Guidelines 2005 (2006): 8th Scientific Congress of the European Resuscitation Council, 10-13 May 2006, Stavanger, Norway.
  61. Speiser-Rankine N., Unterberger W., Taibl R., Payer-Neundlinger G., Mittlböck M. and Strohal R. (2006): Development and implementation of process-oriented skin safety standards for the mineral oil industry: A pilot study. 8th SPE International Conference on Health, Safety and Environment in Oil and Gas Exploration and Production 2006. Vol. 2, 853-863.
  62. Strohal R., Unterberger W., Linemayr J., Mittlböck M. and Payer-Neundlinger G. (2006): Out-door work as potential risk for melanoma. Journal of Investigative Dermatology, Vol.126, S18.
  63. Strohal R., Unterberger W., Taibl R., Mittlböck M. and Payer-Neundlinger G. (2006): Einführung von Hautschutzmaßnahmen in einem Mineralölbetrieb. 8. Internationaler Hautschutztag, 16.-17. Mai 2006, Krefeld, Deutschland.

    2005
  64. Bergmeister H., Böck P., Kasimir M.T., Fleck T., Fitzal F., Husinsky W., Mittlböck M., Stöhr H., Losert U., Wolner E. and Grabenwöger M. (2005): Effect of laser perforation on the remodeling of acellular matrix grafts. Journal of Biomedical Materials Research Part B: Applied Biomaterials, Vol. 74, 495-503.
  65. End A., Schmid K., Birner P., Mittlböck M. and Geleff S. (2005): Lymphatic vessel invasion is a prognostic factor in neuroendeocrine lung tumors. Jahreskongrss der Österreichischen Gesellschaft für Pneumologie, 6-8.Oktober 2005, Vol. 117, A29.
  66. Heinzl H., Mittlböck M. and Edler L. (2005): On the role of ex post uncertainty assessment for risk management. International Journal of Risk Assessment and Management, Vol. 5, 206-215. (paper for download)
  67. Heinzl H., Mittlböck M. and Edler L. (2005): A case of technical uncertainty. 26th Conference of the International Society for Clinical Biostatistics, Szeged, Hungary, p148.

  68. Heinzl H. and Mittlböck M. (2005): An Integrated View on Variability and Uncertainty Represented in the Analysis of a Toxicokinetic Model of Human Life Long Exposure to a Carcinogen. Seminar 2005 der Internationalen Biometrischen Gesellschaft, Region Österreich-Schweiz, Graz.

  69. Heinzl H., Waldhör T. and Mittlböck M. (2005): Careful Use of Pseudo R-Squared Measures in Epidemiological Studies. Statistics in Medicine, Vol. 24, 2867-2872. (paper for download)
  70. Jakesz R., Jonat W., Gnant M., Mittlböck M., Greil R., Tausch C., Hilfrich J., Kwasny W., Menzel C., Samonigg H., Seifert M., Gademann G. and Kaufmann M. on behalf of the ABCSG and the GABG (2005): Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG Trial 8 and ARNO 95 trial. Lancet; Vol. 366, 455-462.
  71. Jakesz R., Gnant M., Greil R., Tausch C., Samonigg H., Kwasny W., Kubista E., Stierer M., Luschin G. and Mittlböck M. (2005): The benefits of sequencing adjuvant tamoxifen and anastrozole in postmenopausal women with hormone-responsive early breast cancer: 5 year-analysis of ABCSG Trial 8. Breast Cancer Research and Treatment. Vol. 94, S10-S10.
  72. Mittlböck M. and Heinzl H. (2005): Generalised measures of explained variation when the distribution of the outcome belongs to the exponential family. Seminar 2005 der Internationalen Biometrischen Gesellschaft, Region Österreich-Schweiz, Graz.

  73. Mittlböck M. and Heinzl H. (2005): Quantifying Heterogeneity in Meta-Analysis. 26th Conference of the International Society for Clinical Biostatistics, Szeged, Hungary, p 93.

  74. Mittlböck M. and Heinzl H. (2005): Pseudo R-squared measures for generalized linear models. In: Biganzoli E, Boracchi P, Duca P, Ifeachor E, editors. Proceedings of the 1st European Workshop on the Assessment of Diagnostic Performance. Napoli: RCE edizioni srl, 71-80.
  75. Schippinger W., Jagoditsch M., Sorré C., Gnant M., Steger G., Hausmanninger H., Mlineritsch B., Schaberl-Moser R., Mischinger H., Hofbauer F., Holzberger P., Mittlböck M. and Jakesz R. for the Austrian Breast and Colorectal Cancer Study Group (2005): A prospective randomised trial to study the role of levamisole and interferon alfa in an adjuvant therapy with 5-FU for stage III colon cancer. British Journal of Cancer, Vol. 92, 1655-1662.
  76. Waldhör T., Vutuc C., Haidinger G, Mittlböck M., Kirchner L., Wald M. (2005): Trends in infant mortality in Austria between 1984 and 2002. Wiener Klinische Wochenschrift, Vol. 117, 548-553.


    2004

  77. Edler L., Heinzl H. and Mittlböck M. (2004): Carrying-over Toxicokinetic Model Uncertainty into Cancer Risk Estimates: The TCDD Example. Organohalogen Compounds, Vol. 66, 3356-3362.
  78. End A., Mittlböck M. and Piza-Katzer H. (2004): Professional satisfaction of women in surgery: results of a national study. Archives of Surgery, Vol.139, 1208-1214.
  79. End, A., Riedl G., Mittlböck M., Müller M., Eckersberger F. and Klepetko W. (2004): Predictors of mortality in bronchial sleeve resections for non-small cell lung cancer. 45. Kongress der Deutschen Gesellschaft für Pneumologie, Frankfurt, Deutschland, V290.
  80. End A., Riedl G., Pentsch A., Krajcuskova K., Mittlböck M., Dekan G., Eckersberger F. and Klepetko W. (2004): Predictors of mortality in bronchial sleeve resections for non-small cell lung cancer. 26.Deutscher Krebskongreß, Berlin, S72.
  81. Fürst G., Reinhard G., Tangl S., Mittlböck M., Sanroman F. and Watzek G. (2004): Effect of platelet-released growth factors and collagen type I on osseous regeneration of mandibular defects. Journal of Clinical Periodontology, Vol.59, 784-790.
  82. Heinzl H. and Mittlböck M. (2004): Design Aspects of a Computer Simulation Study for Assessing Uncertainty in Human Lifetime. Ed.: J. Antoch, COMPSTAT Proceedings in Computational Statistics, 199-211. Prague: Physica-Verlag.
  83. Heinzl H. and Mittlböck M. (2004): Design Aspects of a Computer Simulation Study for Assessing Uncertainty in Human Lifetime. Compstat 2004 Prag, p 133.
  84. Jakesz R., Kaufmann M., Gnant M., Jonat W., Mittlböck M., Greil R., Tausch C., Hilfrich J., Kwasny W. and Samonigg H., on behalf of the ABCSG and ARNO Groups (2004): Benefits of switching postmenopausal women with hormone-sensitive early breast cancer to anastrozole after 2 years adjuvant tamoxifen: combined results from 3,123 women enrolled in the ABCSG Trial 8 and the ARNO 95 Trial. Breast Cancer Research and Treatment, Vol. 88, S7-S7.
  85. Kaczirek K., Schindl M., Weinhäusel A., Scheuba C., Passler C., Prager G., Raderer M., Hamilton G., Mittlböck M., Siegl V., Pfragner R. and Niederle B. (2004): Cytotoxic Activity of Camptothecin and Paclitaxel in Newly Established Continuous Human Medullary Thyroid Carcinoma Cell Lines. The Journal of Clinical Endocrinology and Metabolism, Vol. 85, 2397-2401.
  86. Kasimir M.T., Bialy J., Moidl R., Simon-Kupilik N., Mittlböck M., Hiesmayr M., Wolner E. and Simon P. (2004): EuroSCORE predicts mid-term outcome after combined valve and coronary bypass surgery. The Journal of Heart Valve Disease, Vol. 13, 439-443.
  87. Mittlböck M. (2004): Book Review: Surval Analysis: Techniques for Censored and Truncated Data (Klein and Moeschberger, 2003). Biometrical Journal, Vol. 46, 379.
  88. Mittlböck M. and Heinzl H. (2004): Pseudo R-squared measures for generalized linear models. 1st European Workshop on the Assessment of Diagnostic Performance, 7-9 July 2004, Milano, Italy, 22-23.
  89. Nanobashvili, J, Neumayer C., Fuegl A., Punz A., Blumer R., Mittlböck M., Prager M., Polterauer P., Dobrucki L., Huk I. and Malinski T. (2004), Combined L-arginine and antioxidative vitamin treatment mollifies ischemia/reperfusion injury of skeletal muscle: Journal of Vascular Surgery, Vol. 39, 868-877.
  90. Seitelberger R., Bialy J., Gottardi R., Seebacher G., Moidl R., Mittlböck M., Simon P. and Wolner E. (2004): Relation between size of prosthesis and valve gradient: comparison of two aortic bioprosthesis. European Journal of Cardio-Thoracic Surgery, Vol. 25, 358-363.
  91. Taucher S., Rudas M., Mader R., Gnant M., Dubsky P., Roka S., Bachleitner T., Kandioler D., Steger G., Mittlböck M. and Jakesz R. (2004): Prognostic markers in breast cancer: the reliability of HER/2 neu status in core needle biopsy of 325 patients with primary breast cancer. Wiener Klinische Wochenschrift, Vol. 116, 26-31.
  92. Taucher S., Rudas M., Gnant M., Dubsky P., Sporn E., Roka S., Bachleitner T., Fitzal F., Kandioler D., Wenzel C., Steger G., Draxler W., Mittlböck M. and Jakesz R. (2004): The impact of progesterone receptor in prediciton of complete pathological response to preoperative chemotherapy in primary breast cancer patients. European Surgery - Acta Chirurgica Austriaca 2004, Vol. 36, 41-45.


    2003
  93. Chiari C., Yeganehfar W., Scharitzer M., Mittlböck M., Armbruster C., Roka R., Függer R., Wenzl E., Pokieser P. and Bischof G. (2003): Significant symptomatic relief after transoral endoscopic staple-assisted treatment of Zenker's diverticulum. Surgical Endoscopy, Vol. 17, 596-600.
  94. Benditte-Klepetko H., Koller R., Fügl A., Mittlböck M., Huk I. and Frey M. (2003): L-arginine improves skeletal muscle function after ischemia. Proceedings of the II Congress of the World Society for Reconstructive Microsurgery. Heidelberg, Germany
  95. Exner R., Tamandl D., Götzinger P., Mittlböck M., Függer R., Sautner T., Spittler A., and Roth E.: Perioperative GLY-GLN Infusion Diminishes the Surgery-Induced Period of Immunosuppression: Accelerated Restoration of the Lipopolysaccaride-Stimulated Tumor Necrosis Factor-Alpha Response. Annals of Surgery, Vol. 237, 110-115, 2003
  96. Fuchsjäger M., Maier A., Schima W., Zebedin E., Herbst F., Mittlböck M., Wrba F. and Lechner G. (2003): Comparison of Transrectal Sonography and Double-Contrast MR Imaging When Staging Rectal Cancer. American Journal of Roentgenology, Vol. 181, 421-427.
  97. Giovanoli P., Kamolz L.P., Rab M., Koller R., Mittlböck M. and Frey M. (2003): Limits of Muscle-to-Nerve Ratio in Functional Muscle Transplantation. Journal of Reconstructive Microsurgery, Vol. 19, 21-28.
  98. Heinzl H. and Mittlböck M. (2003): Pseudo R-squared measures for Poisson regression models with over- or under-dispersion. Computational Statistics and Data Analysis, Vol. 44, 253-271. (paper for download)
  99. Heinzl H., Edler L. and Mittlböck M. (2003): Assessing Uncertainty in Toxicokinetic Models Exemplified by the Case of Human Life Long Exposure to TCDD. Bulletin of the International Statistical Institute, 54th Session, Proceedings, Book 1, 477-478.
  100. Kamolz, L. P., Andel, H., Mittlböck, M., Winter, W., Haslik, W., Meissl, G. and Frey, M. (2003): Serum cholesterol and triglycerides: potential role in mortality prediction. Burns, Vol. 29, 810-815.
  101. Kasimir M., Bialy J., Simon-Kupilik N., Hiesmayr M., Mittlböck M., Moidl R., Wolner E. and Simon P. (2003): Euroscore Predicts Mid-term Outcome After Combined Valve and Coronary Bypass Surgery. 2nd Biennial Meeting of The Society for Heart Valve Disease, Paris, France.
  102. Manhart N., Spittler A., Bergmeister H., Mittlböck M. and Roth E. (2003): Influence of Fructooligosaccarides on Peyer's Patch Lymphocyte Numbers in Healthy and Endotoxemic Mice. Nutrition, Vol. 19, 657-660.
  103. Mittlböck M. and Heinzl H. (2003): Explained Variation for Non-normal Outcomes. Proceedings of the Second Workshop on Research Methodology, 47-50, Amsterdam.
  104. Mittlböck M. and Heinzl H. (2003): Explained Variation in Over-/Under-dispersed Poisson Regression Models, Controlled Clinical Trials, Vol. 24, 75.
  105. Mittlböck M. and Heinzl H. (2003): Bias Adjustment for Pseudo R-squared Measures in Over- and Underdispersed Poisson Regression Models. Bulletin of the International Statistical Institute, 54th Session, Proceedings, Book 2, 65-66.
  106. Nanobashvili, J., Neumayer, C., Fügl, A., Punz, A., Blumer, R., Prager, M., Mittlböck, M., Gruber, H., Polterauer, P., Roth, E., Malinski, T. and Huk, I. (2003): Ischaemia/reperfusion injury of skeletal Muscle: Plasma Taurine as a measure of tissue damage. Surgery, 133, 91-100.
  107. Rab M., Beck H., Grünbeck M., Schrögendorfer K.F., Mittlböck M. and Frey M. (2003): Bilateral Carpal Tunnel Syndrome: Intra-individual comparison between open and endoscopic release. 14th Meeting of EURAPS - European Association of Plastic Surgeons, Vienna, Austria.
  108. Taucher S., Rudas M., Gnant M., Thomanek K., Dubsky P., Roka S., Bachleitner T., Kandioler D., Wenzel C., Steger G., Mittlböck M. and Jakesz R. (2003): Sequential steroid hormone receptor measurements in primary breast cancer with and without intervening primary chemotherapy. Endocrine-Related Cancer, Vol. 10, 91-98.
  109. Taucher, S, Rudas M., Mader R., Gnant M., Dubsky P., Bachleitner T., Roka S., Fitzal F., Kandioler D., Sporn E., Mittlböck M. and Jakesz R. (2003), Do we need HER-2/neu testing in all patients with primary breast cancer?: Cancer, Vol. 98, 2547-2553.
  110. Taucher, S., Rudas, M., Mader, R., Gnant, M., Sporn, E., Dubsky, P., Roka, S., Bachleitner, T., Fitzal, F., Kandioler, D., Wenzel, C., Steger, G., Mittlböck, M., & Jakesz, R. (2003): Influence of neoadjuvant therapy with epirubicin and docetaxel on the expression of HER2/neu in patients with breast cancer. Breast Cancer Res.Treat., Vol. 82, 207-213.
  111. Taucher S., Rudas M., Mader R., Gnant M., Dubsky P., Bachleitner T., Roka S., Fitzal F., Kandioler D., Sporn E., Mittlböck M. and Jakesz R. (2003): Do we need HER2/neu testing in all patients with primary breast cancer? Breast Cancer Res. Treat., Vol. 82, 527 Suppl. 1, S127.
  112. Zacherl J., Thein E., Stangl M., Feussner H., Bock S., Mittlböck M., Erhardt W. and Siewert J. (2003): The Influence of Periarterial Papayerine Application on Intraoperative Renal Function and Blood Flow during Laparoscopic Donor Nephrectomy in a Pig Model. Surgical Endoscopy Vol. 17, 1231-1236.
  113. Zettinig G., Asenbaum S., Fueger B., Hofmann A., Diemling M., Mittlböck M. and Dudczak R. (2003): Increased prevalence of sublinical brain perfusion abnormalities in patients with autoimmune thyroiditis - evidence of Hashimoto's encephalitis? Clinical Endocrinology, Vol. 59, 637-643.


    2002
  114. Heinzl, H. and Mittlböck, M. (2002). "R-squared measures for the inverse Gaussian regression model," Computational Statistics, 17, 525-544. (paper for download)
  115. Heinzl, H., Stare, J. and Mittlböck, M. (2002). "A measure of dependence for the stratified Cox proportional hazards regression model," Biometrical Journal, Vol. 44: 671-682. (paper for download)
  116. Mittlböck, M. (2002). "Calculating adjusted R2 measures for Poisson regression models," Comput.Methods Programs Biomed., 68, 205-214. (paper for download)
  117. Mittlböck, M. and Heinzl, H. (2002). "Measures of explained variation in Gamma regression model," Communications in Statistics - Simulation and Computation, 31, 61-73. (paper for download)
  118. Mittlböck, M. and Heinzl, H. (2002): R-squared measures for Poisson and logistic regression models when both models are applicable. XXIst International Biometric Conference 2002, Freiburg, Germany, Abstracts, p 115.
  119. Mittlböck, M. and Heinzl, H. (2002): A note on R-squared measures for Poisson and logistic regression models when both models are applicable. AMM Journal, June 2002, p 24.
  120. Mittlböck, M. and Schemper, M. (2002). "Explained Variation for Logistic Regression - Small Sample Adjustments, Confidence Intervals and Predictive Precision," Biometrical Journal, 44, 263-272. (paper for download)
  121. Simon-Kupilik, N., Bialy, J., Moidl, R., Kasimir, M.T., Mittlböck, M., Seebacher, G., Wolner, E. and Simon, P. (2002): Dilatation of the autograft root after the Ross operation. European Journal of Cardio-thoracic Surgery, Vol. 21 470-473.
  122. Taucher, S., Rudas, M., Gnant, M., Kandioler, D., Pichler, B., Roka, S., Mittlböck, M., Steger, G. and Jakesz, R. (2002): Assessment of HER2/neu status in core needle biopsy of 215 patients with primary breast cancer. European Journal of Cancer, Vol. 38: 270, Suppl. 3.
  123. Taucher S., Rudas M., Gnant M., Dubsky S., Roka S., Bachleitner-Hofman D., Mittlböck M., Steger G., and Jakesz R. (2002): Sequential steroid hormone receptor measurement in breast cancer with and without intervening chemotherapy. European Journal of Surgery, Vol. 34, 186.
  124. Taucher S., Rudas M., Gnant M., Kandioler D., Dubsky S., Roka S., Bachleitner-Hofman D., Mittlböck M., Steger G., and Jakesz R. (2002): Assessment of Her2-neu status in core needle biopsy of 215 patients with primary breast cancer. Breast Cancer Res.Treat., Vol. 76; 60.


    2001
  125. Maier, A., Funovics, M. A., Kreuzer, S. H., Herbst, F., Wunderlich, M., Teleky, B., Mittlböck, M., Schima, W. and Lechner, G. (2001). "Evaluation of perianal sepsis: Comparison of anal endosonography and magnetic resonance imaging," Journal of Magnetic Resonance Imaging, 4, 254-260.
  126. Mittlböck, M. and Heinzl, H. (2001). "A note on R 2 measures for Poisson and logistic regression models when both models are applicable," Journal of Clinical Epidemiology, 54, 99-103. (paper for download)
  127. Trubel W., Czerny M., Schima H., Perktold K., Scheuba C., Ulrich R., Scherer R., Mittlböck M. and Polterauer P. (2001): In-vivo comparison of four different anastomotic techniques in distal popliteal end-to-side anastomoses using e-PTFE bypass grafts. 50th International Congress of the European Society for Cardiovascular Surgery, Budapest.
  128. Waldhör, T., Mittlböck, M., Haidinger, G., Zidek, T. and Schober, E. (2001). "Partial R2-values based on deviance residuals in Poisson regression models.," Zeitschrift für Informatik, Biometrie und Epidemiologie in Medizin und Biologie, 32, 341-347.


    2000
  129. Felfernig-Boehm, D., Salat, A., Vogl, S. E., Murabito, M., Felfernig, M., Schmidt, D., Mittlböck, M., Husslein, P. and Müller, M. R. (2000). "Early detection of preeclampsia by determination of platelet aggregability [In Process Citation]," Thromb.Res., 98, 139-146.
  130. Giovanoli, P., Koller, R., Meuli-Simmen, C., Rab, M., Haslik, W., Mittlböck, M., Meyer, V. E. and Frey, M. (2000). "Functional and morphometric evaluation of end-to-side neurorrhaphy for muscle reinnervation," Plast Reconstr Surg, 106, 383-392.
  131. Gollackner, B., Sedivy, R., Rockenschaub, S., Casati, B., Wrba, F., Langer, F., Mittermayer, C., Mittlböck, M., Mühlbacher, F. and Steininger, R. (2000). "Increased apoptosis of hepatocytes in vascular occlusion after orthotopic liver transplantation," Transpl.Int., 13, 49-53.
  132. Gollackner, B., Längle, F., Auer, H., Maier, A., Mittlböck, M., Agstner, I., Karner, J., Langer, F., Aspock, H., Loidolt, H., Rockenschaub, S. and Steininger, R. (2000). "Radical Surgical Therapy of Abdominal Cystic Hydatid Disease: Factors of Recurrence," World J.Surg., 24, 717-721.
  133. Kandioler-Eckersberger, D., Ludwig, C., Rudas, M., Kappel, S., Janschek, E., Wenzel, C., Schlagbauer-Wadl, H., Mittlböck, M., Gnant, M., Steger, G. and Jakesz, R. (2000). "TP53 mutation and p53 overexpression for prediction of response to neoadjuvant treatment in breast cancer patients," Clin.Cancer Res., 6, 50-56.
  134. Minar, E., Pokrajac, B., Maca, T., Ramazanali, A., Fellner, C., Mittlböck, M., Seitz, W., Wolfram, R. and Pötter, R. (2000). "Endovascular brachytherapy for phrophylaxis of restenosis after femoropopliteal angioplasty. Results of a prospective randomized study," Circulation, 102, 2694-2699.
  135. Mittlböck, M. and Waldhör, T. (2000). "Adjustments for R2-measures for Poisson regression models," Computational Statistics and Data Analysis, 34, 461-472. (paper for download)
  136. Pokrajac, B., Pötter, R., Maca, T., Fellner, C., Mittlböck, M., Ahmadi, R., Seitz, W. and Minar, E. (2000). "Intraarterial 192Ir HDR Brachytherapy for Prohylaxix of Restenosis after Femoropopliteal Percutaneous Transluminal Angioplasty: The Prospective Randomized Vienna-2-Trial. Radiotherapy Parameters and Risk Factors Analysis," Int J Radiat Oncol Biol Phys, 48, 923-931.


    1999
  137. Bergmann, M., Gornikiewicz, A., Sautner, T., Waldmann, E., Weber, T., Mittlböck, M., Roth, E. and Függer, R. (1999). "Attenuation of catecholamine-induced immunosuppression in whole blood from patients with sepsis," Shock, 12, 421-427.
  138. Jakesz, R., Hausmaninger, H., Haider, K., Kubista, E., Samonigg, H., Gnant, M., Manfreda, D., Tschurtschenthaler, G., Kolb, R., Stierer, M., Fridrik, M., Mlineritsch, B., Steindorfer, P., Mittlböck, M. and Steger, G. (1999). "Randomized trial of low-dose chemotherapy added to tamoxifen in patients with receptor-positive and lymph node-positive breast cancer," J.Clin.Oncol., 17, 1701-1709.
  139. Kandioler-Eckersberger, D., Kappel, S., Mittlböck, M., Dekan, G., Ludwig, C., Janschek, E., Pirker, R., Wolner, E. and Eckersberger, F. (1999). "The TP53 genotype but not immunohistochemical result is predictive of response to cisplatin-based neoadjuvant therapy in stage III non-small cell lung cancer," J.Thorac.Cardiovasc.Surg., 117, 744-750.
  140. Kappel S., Kandioler-Eckersberger D., Ludwig C., Dekan G., Mittlböck M., Janschek E., Penz M., Krajnik G., Pirker R., Mannhalter C., Wolner E. and Eckersberger F. (1999): Vorhersage des Ansprechens auf präoperative Induktionstherapie beim fortgeschrittenen Lungenkarzinom durch P53-Sequenzanalyse. Acta Chirurgica Austriaca, Vol. Suppl. 153, 105-106.
  141. Knabl, J. S., Bauer, W., Andel, H., Schwendenwein, I., Dado, P. F., Mittlböck, M., Romer, W., Choi, M. S., Horvat, R., Meissl, G. and Frey, M. (1999). "Progression of burn wound depth by systemical application of a vasoconstrictor: an experimental study with a new rabbit model," Burns, 25, 715-721.
  142. Kucera, E., Speiser, P., Gnant, M., Szabo, L., Samonigg, H., Hausmaninger, H., Mittlböck, M., Fridrik, M., Seifert, M., Kubista, E., Reiner, A., Zeillinger, R., Jakesz, R. and the Austrian Breast Cancer Study Group (1999). "Prognostic significance of mutations in the p53 gene, particularly in the zinc-binding domains, in lymph node- and steroid receptor positive breast cancer patients," Eur.J.Cancer, 35, 398-405.
  143. Mittlböck,M. and Heinzl,H. (1999): Adjustment for R-squared measure in Poisson regression. International Society for Clinical Biostatistics 99, Heidelberg, Deutschland, p 296.
  144. Mittlböck, M. and Schemper, M. (1999). "Computing measures of explained variation for logistic regression models," Computer Methods and Programs in Biomedicine, 58, 17-24. (paper for download)
  145. Moidl, R., Chevtchik, O., Simon, P., Grimm, M., Wieselthaler, G., Ullrich, R., Mittlböck, M., Wolner, E. and Laufer, G. (1999). "Noninvasive monitoring of peak filling rate with acoustic quantification echocardiography accurately detects acute cardiac allograft rejection," J.Heart Lung Transplant., 18, 194-201.
  146. Müllner, T., Nikolic, A., Kubiena, H., Kainberger, F., Mittlböck, M. and Vécsei, V. (1999). "The role of magnetic resonance imaging in routine decision making for meniscal surgery," Knee.Surg.Sports Traumatol.Arthrosc., 7, 278-283.
  147. Müllner, T., Kaltenbrunner, W., Nikolic, A., Mittlböck, M., Schabus, R. and Vécsei, V. (1999). "Anterior cruciate ligament reconstruction alters the patellar alignment," Arthroscopy, 15, 165-168.
  148. Rebhandl W., Rami B., Turnbull J., Felberbauer F.X., Paya K., Gherardini R., Mittlböck M. and Horcher E. (1999): Diagnostic Value of Tissue Polypeptide-specific Antigen (TPS) in Neuroblastoma and Wilms Tumor. Acta Chirurgica Austriaca, Vol. Suppl. 153, 71-72.
  149. Spittler, A., Reissner, C. M., Öhler, R., Gornikiewicz, A., Grünberger, T., Manhart, N., Brodowicz, T., Mittlböck, M., Boltz-Nitulescu, G. and Roth, E. (1999). "Immunomodulatory effects of glycine on LPS-treated monocytes: reduced TNF-alpha production and accelerated IL-10 expression," FASEB J., 13, 563-571.


    1998
  150. Dock, W., Turkof, E., Maier, A., Metz, V., Puig, S., Mittlböck, M., Eibenberger, K., Lechner, G. and Polterauer, P. (1998). "Prävalenz des abdominellen Aortenaneurysmas: Eine sonographische Screeningstudie," Rofo Fortschr.Geb.Rontgenstr.Neuen Bildgeb.Verfahr., 168, 356-360.
  151. Gollackner B., Steininger R., Pravica V., Rockenschaub S., Öhler R., Perrey C., Sinnott P., Mittlböck M., Langer F., Roth E., Hutchinson I.V. and Mühlbacher F. (1998): Polymorphisms of transforming growth factor Beta-1 (TGF-B) genotype and its impact on development of alcoholic liver cirrhosis. Hepatology, Vol. 28, Suppl. S, p 640A.
  152. Gollackner B., Steininger R., Pravica V., Rockenschaub S., Öhler R., Perrey C., Sinnott P., Mittlböck M., Langer F., Roth E., Hutchinson I.V. and Mühlbacher F. (1998): Spielen die genetischen Polymorphismen des Transforming Growth Factor Beta-1 (TGF-B) eine Rolle in der Entwicklung einer alkoholischen Leberzirrhose. Acta Chirurgica Austriaca, Vol. Suppl. 146, p 7.
  153. Grünberger T., Gorlitzer M., Mittlböck M., Axner I., Rudas M., Kandioler D., Taucher S., Gebhard B., Steger g., Gnant M. and Jakesz R. (1998): Adjuvant radiotherapy has no benefit after primary breast cancer treatment in selected postmenopausal patients. European Journal of Cancer, Vol 34, Suppl 1, p 31.
  154. Grünberger T., Gorlitzer M., Mittlböck M., Axner I., Rudas M., Kandioler D., Taucher S., Gebhard B., Steger g., Gnant M. and Jakesz R. (1998): Adjuvant radiotherapy has no benefit after primary breast cancer treatment in selected postmenopausal patients. British Journal of Surgery, Vol 85, Suppl 2, p 32.
  155. Grünberger, T., Gorlitzer, M., Soliman, T., Rudas, M., Mittlböck, M., Gnant, M., Reiner, A., Teleky, B., Seitz, W. and Jakesz, R. (1998). "It is possible to omit postoperative irradiation in a highly selected group of elderly breast cancer patients," Breast Cancer Res.Treat., 50, 37-46.
  156. Huk, I., Nanobashvili, J., Orljanski, W., Neumayer, C., Punz, A., Holzäpfel, A., Fügl, A., Mittlböck, M., Polterauer, P. and Roth, E. (1998). "L-arginine treatment in ischemia/reperfusion injury," Cas.Lek.Cesk., 137, 496-499.
  157. Jakesz, R., Samonigg, H., Gnant, M., Kubista, E., Steindorfer, P., Hausmaninger, H., Sevelda, P., Tschurtschenthaler, B., Fridrik, M., Stierer, M., Kolb, R., Steger, G., Mittlböck, M. and the Austrian Breast Cancer Study Group (1998). "Very Low-dose Adjuvant Chemotherapy in Steroid Receptor Negative Stage I Breast Cancer Patients," European Journal of Cancer, 34, 66-70.
  158. Mittlböck,M. (1998): Adjusted R-squared Measures in Poisson Regression. The 19th International Biometric Conference, Cape Town, South Africa, Abstracts, 211.
  159. Mittlböck, M. and Whitehead, J. (1998). "The interpretation of clinical trials of immediate versus delayed therapy," Lifetime Data Analysis, 4, 253-263. (paper for download)
  160. Müllner, T., Reihsner, R., Mrkonjic, L., Kaltenbrunner, W., Kwasny, O., Schabus, R., Mittlböck, M. and Vécsei, V. (1998). "Twisting of patellar tendon grafts does not reduce their mechanical properties," J.Biomech., 31, 311-315.
  161. Müllner, T., Kaltenbrunner, W., Nikolic, A., Mittlböck, M., Schabus, R. and Vécsei, V. (1998). "Shortening of the patellar tendon after anterior cruciate ligament reconstruction," Arthroscopy, 14, 592-596.
  162. Paya, K., Rebhandl, W., Urbania, A., Leberl, K., Glaser, C., Mittlböck, M. and Horcher, E. (1998). "Is Diagnostic Laparoscopy Justified in Children with Recurrent Abdominal Pain?," Acta Chirurgica Austriaca, 30, 344-348.
  163. Rebhandl, W., Rami, B., Turnbull, J., Felberbauer, F. X., Paya, K., Bancher-Todesca, D., Gherardini, R., Mittlböck, M. and Horcher, E. (1998). "Diagnostic value of tissue polypeptide-specific antigen (TPS) in neuroblastoma and Wilms' tumour," Br.J.Cancer, 78, 1503-1506.
  164. Sedivy, R., Gollackner, B., Casati, B., Mittlböck, M., Kaserer, K., Steininger, R. and Wrba, F. (1998). "Apoptotic hepatocytes in rejection and vascular occlusion in liver allograft specimens," Histopathology, 32, 503-507.
  165. Yeganehfar, W., Wamser, P., Rockenschaub, S., Schindl, M., Mittlböck, M., Eisenhuber, E., Madl, C., Längle, F., Berlakovich, G., Mühlbacher, F. and Steininger, R. (1998). "Lebertransplantation bei akutem Leberversagen," Wien.Klin.Wochenschr., 110, 570-578.


    1997
  166. Gäbler, C., Kukla, C., Breitenseher, M. J., Nellas, Z. J., Mittlböck, M., Trattnig, S. and Vécsei, V. (1997). "Diagnosis of lateral ankle ligament injuries. Comparison between talar tilt, MRI and operative findings in 112 athletes," Acta Orthop.Scand., 68, 286-290.
  167. Grabenwöger, M., Ehrlich, M., Cartes-Zumelzu, F., Mittlböck, M., Weigel, G., Laufer, G., Wolner, E. and Havel, M. (1997). "Surgical treatment of aortic arch aneurysms in profound hypothermia and circulatory arrest," Ann.Thorac.Surg., 64, 1067-1071.
  168. Grünberger T., Gnant M., Mittlböck M., Axner I., Kandioler D., Taucher S., Gebhart B., Steger G. and Jakesz R. (1997): Age as an independent risk factor for relapse after primary breast cancer treatment in 1873 elderly patients. ASCO Proceedings, Vol. 16, 475.
  169. Grünberger T., Gorlitzer M, Soliman Th, Mittlböck M., Agstner I., Kandioler D., Taucher S., Gebhard B., Steger G., Gnant M. and Jakesz R. (1997): Muß jede Patientin mit einem Mammakarzinom nach brusterhaltender Operation adjuvant bestrahlt werden? In: Standards in der Diagnostik und Therapie des Mammakarzinoms, Ambrosius Barth Verlag, Heidelberg-Leipzig.
  170. Huk, I., Nanobashvili, J., Neumayer, C., Punz, A., Müller, M., Afkhampour, K., Mittlböck, M., Losert, U., Polterauer, P., Roth, E., Patton, S. and Malinski, T. (1997). "L-arginine treatment alters the kinetics of nitric oxide and superoxide release and reduces ischemia/reperfusion injury in skeletal muscle," Circulation, 96, 667-675.
  171. Karner-Hanusch, J., Mittlböck, M., Fillipitsch, T. and Herbst, F. (1997). "Family history as a marker of risk for colorectal cancer: Austrian experience," World J.Surg., 21, 205-209.
  172. Längle, F., Steininger, R., Waldmann, E., Grünberger, T., Benditte, H., Mittlböck, M., Soliman, T., Schindl, M., Windberger, U., Mühlbacher, F. and Roth, E. (1997). "Improvement of cardiac output and liver blood flow and reduction of pulmonary vascular resistance by intravenous infusion of L-arginine during the early reperfusion period in pig liver transplantation," Transplantation, 63, 1225-1233.
  173. Mittlböck,M. and Whitehead,J. (1997): Clinical trials of immediate versus delayed therapy: Extrapolation to comparison with a pure control. Joint Statistical Meetings 97 of the American Statistical Association, Anaheim, USA, p 363.
  174. Mittlböck,M. and Whitehead,J. (1997): Klinische Studien mit sofort und verzögert verabreichter Therapie-Verallgemeinerung zu einem Vergleich mit reiner Kontrollgruppe. Österreichische Statistik-Tage 1997, Wien.
  175. Mittlböck, M. and Schemper, M. (1997). "Erklärte Variabilität bei Logistischer Regression unter Verwendung von SAS," 1.Konferenz der SAS-Benutzer in Forschung und Entwicklung (KSFE), Humboldt-Universität Berlin, Konferenzbeiträge, 1, 242-253.
  176. Mittlböck,M. and Schemper,M. (1997): Erklärte Variabilität bei Logistischer Regression. 1.Konferenz der SAS-Benutzer in Forschung und Entwicklung (KSFE), Humboldt-Universität Berlin, Deutschland.
  177. Mittlböck,M. and Whitehead,J. (1997): Die Interpretation von Klinischen Studien mit sofort und verzögert verabreichter Therapie. Seminar der Region Österreich-Schweiz der Internationalen Biometrischen Gesellschaft, Wien.
  178. Müller, M. R., Salat, A., Stangl, P., Murabito, M., Pulaki, S., Böhm, D., Koppensteiner, R., Ergun, E., Mittlböck, M., Schreiner, W., Losert, U. and Wolner, E. (1997). "Variable platelet response to low-dose ASA and the risk of limb deterioration in patients submitted to peripheral arterial angioplasty," Thromb.Haemost., 78, 1003-1007.
  179. Reiner, A., Rudas, M., Neumayer, R., Gnant, M., Mittlböck, M. and Jakesz, R. (1997). "Protein p53 Expression, Cell Proliferation and Steroid Hormone Receptors in Ductal Carcinoma in situ of the Breast," Acta Chirurgica Austriaca, 29, 123-125.
  180. Rudas, M., Neumayer, R., Gnant, M. F., Mittlböck, M., Jakesz, R. and Reiner, A. (1997). "p53 protein expression, cell proliferation and steroid hormone receptors in ductal and lobular in situ carcinomas of the breast," Eur.J.Cancer, 33, 39-44.
  181. Rudas, M., Neumayer, R., Gnant, M. F., Mittlböck, M., Jakesz, R. and Reiner, A. (1997). Comments on p53 protein expression, cell proliferation and steroid hormone receptors in ductal and lobular in situ carcinomas of the breast, - Response. European Journal of Cancer, 33, 1904-1904.


  182. Speiser, P., Mayerhofer, K., Kucera, E., Roch, G., Mittlböck, M., Gitsch, G. and Zeillinger, R. (1997). "pS2 and PAI-1 in ovarian cancer: correlation to pathohistological parameters," Anticancer Res., 17, 679-683.
  183. Speiser, P., Wanner, C., Tempfer, C., Mittlböck, M., Hanzal, E., Bancher-Todesca, D., Gitsch, G., Reinthaller, A. and Kainz, C. (1997). "CD44 is an independent prognostic factor in early-stage cervical cancer," Int.J.Cancer, 74, 185-188.


    1996
  184. Bacher, A., Mayer, N., Mittlböck, M. and Zadrobilek, E. (1996). "Anaesthesia and systemic oxygenation," Acta Anaesthesiol.Scand., 40, 869-875.
  185. Bischof,G., Mittlböck,M., Sporn,S., Herbst,F., Karner-Hanusch,J., Teleky,B., and Wenzl,E. (1996): Nachsorge des kolorektalen Karzinoms. Acta Chirurgica Austriaca, 28, Suppl. 121:81.
  186. Gäbler, C., Kukla, C., Breitenseher, M., Trattnig, S., Mittlböck, M. and Vécsei, V. (1996). "Magnetic resonance imaging of occult scaphoid fractures," J.Trauma, 41, 73-76.
  187. Grünberger, T., Gorlitzer, M., Soliman, T., Rudas, M., Mittlböck, M., Götzinger, P., Gnant, M., Reiner, A., Teleky, B., Seitz, W. and Jakesz, R. (1996). "Kommentare und Schlußwort der Autoren zu: Kann man einer hochselektionierten Patientinnengruppe nach brusterhaltender Therapie wegen Mammakarzinoms die Postoperative Nachbestrahlung ersparen? [in: Acta Chir. Austriaca, Vol. 27, (1995) 269-273]," Acta Chirurgica Austriaca, 23, 124-127.
  188. Grünberger, T., Windhager, T., Gnant, M., Mittlböck, M., Steininger, R., Herbst, F. and Mühlbacher, F. (1996). "Tumor recurrence after oLTX," Transpl.Int., 9, Suppl. 1, S151-S154.
  189. Hoda,R., Heinrich,N., Rödler,S., Podesser,B., Moidl,R., Mittlböck,M., Moritz,A., Laufer,G., and Wolner,E. (1996): Veränderung der subjektiven Beeinträchtigung der Lebensqualität von Patienten nach Klappenersatz mit mechanischen Doppelflügelprothesen. 37.Tagung der Österreichischen Gesellschaft für Chirurgie, Graz.
  190. Huk, I., Nanobashvili, J., Punz, A., Lassner, H., Müller, M., Siegl, H., Neumayer, C., Mittlböck, M. and Roth, E. (1996). "Influence of a short-term acute ischemia and reperfusion on skeletal muscle metabolism and Morphology in rabbits," Internat.Journal of Angiology, 5, 59-63.
  191. Huk,I., Nanobashvili,J., Neumayer,C., Punz,A., Müller,M., Flügl,A., Nakhai,S., Afkhampour,K., Partyka,L., Mittlböck,M., Losert,U., Roth,E., Polterauer,P., and Malinski,T. (1996): Direkte Stickstoffoxidmessungen an Kapillaren während Ischaemie/Reperfusion: Effekt von L-Arginin. 1.Fakultätsvorlesung des Vereins zur Förderung von Wissenschaft und Forschung, Wien.
  192. Huk,I., Nanobashvili,J., Neumayer,C., Holzäpfel,A., Punz,A., Siegl,H., Seljouk,V., Mittlböck,M., Polterauer,P., Losert,U., and Roth,E. (1996): Einfluß der Ischämiedauer auf morphologische Veränderung der Skelettmuskulatur, insbesondere auf die Kapillargröße. Acta Chirurgica Austriaca, 28, Suppl. 121:43.
  193. Huk,I., Nanobashvili,J., Neumayer,C., Holzäpfel,A., Punz,A., Siegl,H., Müller,M., Mittlböck,M., Polterauer,P., Losert,U., and Roth,E. (1996): Aminosäurestoffwechsel bei Ischämie/Reperfusion im Skelettmuskel und Einfluß einer L-Argininbehandlung. 12.Jahrestagung der Deutschen Gesellschaft für Gefäßchirurgie, München, Deutschland.
  194. Mittlböck,M. and Schemper,M. (1996): Explained variation for logistic regression. The 18th International Biometric Conference, Amsterdam, Netherlands, 65-65.
  195. Mittlböck,M. and Schemper,M. (1996): Erklärte Variabilität bei Logistischer Regression. 42.Biometrisches Kolloquium der Deutschen Region, Internationale Biometrische Gesellschaft, Magdeburg, Deutschland, 60.
  196. Mittlböck,M. and Schemper,M. (1996): Explained variation for logistic regression. Biometric Bulletin of the International Biometric Society, 13:8.
  197. Mittlböck, M. and Schemper, M. (1996). "Explained variation for logistic regression," Statistics in Medicine, 15, 1987-1997. (paper for donwload)
  198. Sautner,T., Riegler,M., Wessely,C., Mittlböck,M., Sogukolglu,T., Götzinger,P., and Függer,R. (1996): Intestinal and Hepatic oxygen delivery are not improved by catecholamines in endotoxin shock despite increased systemic oxygen dlivery. British Journal of Surgery, 83:847.
  199. Weingartmann, G., Fridrich, P., Mauritz, W., Götzinger, P., Mittlböck, M., Germann, P., Karner, J. and Roth, E. (1996). "Safety and efficacy of increasing dosages of glycyl-glutamine for total parenteral nutrition in polytrauma patients," Wien.Klin.Wochenschr., 108, 683-688.


    1995
  200. Berlakovich, G. A., Steininger, R., Herbst, F., Barlan, M., Mittlböck, M. and Mühlbacher, F. (1995). "Ergebnisse der Lebertransplantation wegen alkoholischer Zirrhose mit Berücksichtigung von Rezidiv und Patientenzuverläßigkeit," Österreichische Transplantationsnachrichten, 2, 12-21.
  201. Függer, R., Götzinger, P., Sautner, T., Mittlböck, M., Rogy, M., Adamer, K. and Fritsch, A. (1995). "Necrosectomy and laparostomy - a combined therapeutic concept in acute necrotising pancreatitis," Eur.J.Surg., 161, 103-107.
  202. Grünberger, T., Gorlitzer, M., Soliman, T., Rudas, M., Mittlböck, M., Götzinger, P., Gnant, M., Reiner, A., Teleky, B., Seitz, W. and Jakesz, R. (1995). "Kann man einer hochselektionierten Patientinnengruppe nach brusterhaltender Therapie wegen Mammakarzinoms die postoperative Nachbestrahlung ersparen?," Acta Chirurgica Austriaca, 27, 269-273.
  203. Huk,I., Nanobashvili,J., Neumayer,C., Holzapfel,A., Punz,A., Müller,M., Siegl,H., Seljouk,V., Mittlböck,M., Polterauer,P., Losert,U., and Roth,E. (1995): Kapillargrößeveränderungen bei Ischämie/Reperfusion in der Skelettmuskulatur und Effekt einer L-Arginin-Behandlung. Acta Medica Austriaca, 22, Sonderheft 1:39.
  204. Huk,I., Nanobashvili,J., Neumayer,C., Müller,M., Siegl,H., Mittlböck,M., Dryuk,M., Deckstein,M., Polterauer,P., and Roth,E. (1995): Capillar caliber changes, oxygen free radicals and thromboxane A2 synthesis in rabbit skeletal muscle during ischaemia/reperfusion injury. 37th Annual World Congress of the International College of Angiology, Helsinki, Finland.
  205. Mittlböck,M. (1995): Explained Variation for Logistic Regression. 16th Meeting of the International Society for Clinical Biostatistics, Barcelona, Spain, 104.
  206. Neumayer, C., Nanobashvili, J., Huk, I., Siegl, H., Seljouk, V., Mittlböck, M. and Gruber, H. (1995). "Morphometry for quantification of skeletal muscle reperfusion injury in rabbit model," Proceedings of the 4th International Muscle Symposium, Zürich, 247-250.
  207. Salat,A., Karner-Hanusch,J., Mittlböck,M., Stangl,P., and Polterauer,P. (1995): Der Stellenwert des Diabetes in der Gefäßchirurgie. Acta Medica Austriaca, 22, Sonderheft 1:40.
  208. Salat,A., Karner-Hanusch,J., Mittlböck,M., and Polterauer,P. (1995): Gefäßchirurgie und Rauchen - eine retrospektive multivariate Analyse. Acta Medica Austriaca, 22, Sonderheft 1:39-40.
  209. Sautner, T., Függer, R., Götzinger, P., Mittlböck, M., Winkler, S., Roth, E., Steininger, R. and Mühlbacher, F. (1995). "Tumour necrosis factor-a and interleukin-6: early indicators of bacterial infection after human orthotopic liver transplantation," Eur.J.Surg., 161, 97-101.


    1994
  210. Berlakovich, G. A., Herbst, F., Mittlböck, M. and Kretschmer, G. (1994). "The choice of material for above-knee femoropopliteal bypass. A 20-year experience," Arch.Surg., 129, 297-302.
  211. Berlakovich, G. A., Steininger, R., Herbst, F., Barlan, M., Mittlböck, M. and Mühlbacher, F. (1994). "Transplantation for alcoholic cirrhosis: How does recurrence of disease harm the graft?," Transplant International, 7, Suppl. 1, 123-127.
  212. Berlakovich, G. A., Steininger, R., Herbst, F., Barlan, M., Mittlböck, M. and Mühlbacher, F. (1994). "Efficacy of liver transplantation for alcoholic cirrhosis with respect to recidivism and compliance," Transplantation, 58, 560-565.
  213. Grünberger, T., Steininger, R., Sautner, T., Mittlböck, M. and Mühlbacher, F. (1994). "Influence of donor graft function after orthotopic liver Transplantation," Transplantation International, 7, 672-674.
  214. Herbst,F., Sautner,T., Telfeyan,D., Mittlböck,M., Karner-Hanusch,J., Teleky,B., and Fritsch,A. (1994): Einfluß des Beckenrezidivs auf die Prognose nach Rektumkarzinom. Acta Chirurgica Austriaca, 26, Suppl. 107:109.
  215. Huk,I., Nanobashvili,J., Roth,E., Neumayer,C., Siegl,H., Müller,M., Punz,A., Lassner,H., Seljouk,V., and Mittlböck,M. (1994): Biochemische und Morphometrische Parameter in einem in vivo Reperfusionsmodell am Kaninchen. Acta Chirurgica Austriaca, 26, Suppl. 111:2.
  216. Karner-Hanusch, J., Mittlböck, M., Salat, A., Pichl, K. and Polterauer, P. (1994). "Gefäßchirurgie und Rauchen - eine retrospektive multivariate Analyse," Wien.Med.Wochenschr., 144, 561-565.
  217. Längle, F., Abela, C., Koller-Strametz, J., Mittlböck, M., Bergler-Klein, J., Stefenelli, T., Woloszczuk, W. and Niederle, B. (1994). "Primary hyperparathyroidism and the heart: cardiac abnormalities correlated to clinical and biochemical data," World J.Surg., 18, 619-624.
  218. Mittlböck,M. (1994): An analysis using the regression model of Cox with time-dependent covariates. Joint Statistical Meetings 94 of the American Statistical Association, Toronto, Canada, Abstracts, 144.
  219. Mittlböck,M. (1994): Ideas and methods resulting from the seminal paper of Mantel and Haenszel. The 17th International Biometric Conference, Hamilton, Canada, Abstracts, 162.
  220. Rudas, M., Gnant, M. F., Mittlböck, M., Neumayer, R., Kummer, A., Jakesz, R., Reiner, G. and Reiner, A. (1994). "Thymidine labeling index and Ki-67 growth fraction in breast cancer: comparison and correlation with prognosis," Breast Cancer Res.Treat., 32, 165-175.
  221. Salat, A., Karner-Hanusch, J., Mittlböck, M., Kretschmer, G. and Polterauer, P. (1994). "Diabetes Mellitus und Gefäßchirurgie: Eine retrospektive Analyse," Acta Med.Austriaca, 21, 100-102.
  222. Zadrobilek,E., Steiner,P., Watzl,C., Mittlböck,M., and Bacher,A. (1994): Failure to determine the anaerobic threshold of oxygen delivery (DO2I) in perioperative patients. Intensive Care Medicine, 20, Suppl. 2.


    1993
  223. Berlakovich,G.A., Steininger,R., Herbst,F., Mittlböck,M., Walgram,M., and Mühlbacher,F. (1993): Transplantation for alcoholic cirrhosis: How does recurrence of disease harm the graft? 6th Congress of the European Society for Organ Transplantation, Rhodos, Greece.
  224. Bischof, G., Pratschner, T., Kail, M., Mittlböck, M., Turkof, E., Puig, S., Polterauer, P. and Kretschmer, G. (1993). "Anticoagulants, antiaggregants or nothing following carotid endarterectomy?," Eur.J.Vasc.Surg., 7, 364-369.
  225. Danninger, R., Mittlböck, M. and Wahl, S. (1993). "Vergleich der Meßwerte von Hitachi 737 und Hitachi 704 in zwei verschiedenen Laboratorien," Labor Aktuell, 7, 9-13.
  226. Függer,R., Salat,A., Magometschnigg,H., Mittlböck,M., Kretschmer,G., and Polterauer,P. (1993): Langzeitprophylaxe nach arteriellen Beckenrekonstruktionen - Einfluß auf Graftfunktion und Überleben. Angio Archiv, 25:82.
  227. Függer, R., Zadrobilek, E., Götzinger, P., Klimann, S., Rogy, M., Winkler, S., Andel, H., Mittlböck, M., Roth, E. and Schulz, F. (1993). "Perioperative TNFa and IL-6 concentrations correlate with septic state, organ function, and APACHE II scores in intra-abdominal infection," Eur.J.Surg., 159, 525-529.
  228. Grünberger, T., Sautner, T., Wamser, P., Mittlböck, M., Steininger, R. and Mühlbacher, F. (1993). "Impact of donor criteria on postoperative graft function in liver transplantation," Transplant.Proc., 25, 3156-3157.
  229. Karner-Hanusch,J., Mittlböck,M., and Polterauer,P. (1993): Rauchen und Gefäßchirurgie: Eine retrospektive multivariate Analyse. Angio Archiv, 25:71.
  230. Kretschmer, G., Bischof, G., Pratschner, T., Kail, M., Mittlböck, M., Turkof, E., Puig, S. and Polterauer, P. (1993). "Antiplatelet or anticoagulant therapy after carotid endarterectomy: Results of a trial and an analysis supported by postdata matching," in: R.M.Greenhalgh, et al (ed), Surgery for Stroke, W.B.Saunders Company LTD, London, 319-327.
  231. Mittlböck,M. (1993): An analysis of patients with primary breast-cancer using the proportional hazard model of Cox with time-dependent covariates. 14th Meeting of the International Society of Clinical Biostatistics, Cambridge, Abstracts, 158.
  232. Mittlböck,M. (1993): Die Idee von Mantel und Haenszel (1959) und daraus resultierende Entwicklungen. Seminar 93 der Internationalen Biometrischen Gesellschaft, Region Österreich-Schweiz, Innsbruck, Abstracts, 26-27.
  233. Rudas,M., Furrer,A., Freilinger,M., Neumayer,R., Mittlböck,M., Gnant,M., Jakesz,R., and Reiner,A. (1993): Proliferationsmarker beim Mammakarzinom - ein Vergleich zwischen PCNA, Ki-67 und TLI. Acta Chirurgica Austriaca, 25, Suppl. 103:29.
  234. Salat,A., Mittlböck,M., Karner-Hanusch,J., and Polterauer,P. (1993): Diabetes und Gefäßchirurgie: Eine retrospektive multivariate Analyse. Angio Archiv, 25:72.
  235. Sautner,T., Függer,R., Götzinger,P., Mittlböck,M., Winkler,S., Roth,E., Steininger,R., and Mühlbacher,F. (1993): Tumour necrosis factor-a and interleukin-6: early indicators of bacterial infection after human orthotopic liver transplantation. Surgical Infection Society - Europe, 6th Annual Meeting, Varese, Italy, 24.
  236. Sautner, T., Mittlböck, M., Herbst, F., Schwartz, D. and Mühlbacher, F. (1993). "HLA-B mismatch: an equally strong prognostic factor for kidney transplantation when compared with HLA-DR mismatch," Transplant.Proc., 25, 224-225.
  237. Teleky,B., Teufelsbauer,H., Mittlböck,M., Huk,I., Stuempflen,A., Ugurluoglu,A., Ehringer,H., Kretschmer,G., and Polterauer,P. (1993): Therapie von proximalen Subclavialaesionen: Transposition versus Bypass. Angio Archiv, 25:38.


    1992
  238. Függer,R., Zadrobilek,E., Klimann,S., Winkler,S., Mittlböck,M., Rogy,M., Andel,H., Roth,E., Schulz,F., and Fritsch,A. (1992): Perioperative TNF and IL-6 correlate with the severity of sepsis and organ dysfunction in abdominal infection. European Cytokine Network, 3:251.
  239. Gnant, M. F., Seifert, M., Jakesz, R., Adler, A., Mittlböck, M. and Sevelda, P. (1992). "Breast cancer and timing of surgery during menstrual cycle. A 5-year analysis of 385 pre-menopausal women," Int.J.Cancer, 52, 707-712.
  240. Götzinger,P., Winkler,S., Mittlböck,M., Steininger,R., Mühlbacher,F., Roth,E., and Függer,R. (1992): Intraoperative release of TNF and IL-6 during human liver transplantation is dependent from plasma endotoxin. 2nd Conference of the International Endotoxin Society, Vienna.
  241. Karner-Hanusch,J., Prager,M., Mittlböck,M., Polterauer,P., and Kretschmer,G. (1992): Die periphere arterielle Embolektomie: Welche Risikofaktoren beeinflußen das Langzeitüberleben betroffener Patienten. Acta Chirurgica Austriaca, 24, Suppl. 98:127.
  242. Mittlböck,M. and Schemper,M. (1992): The seminal paper by Mantel and Haenszel and resulting developments. Joint Statistical Meetings 92 of the American Statistical Association, Boston, USA, 160.
  243. Mittlböck,M. (1992): Reviewing methods based on the seminal paper by Mantel and Haenszel. 13th Meeting of the International Society for Clinical Biostatistics, Copenhagen, Denmark, 86.
  244. Reiner, A., Jakesz, R., Reiner, G., Mittlböck, M., Gnant, M., Neumeister, B. and Spona, J. (1992). "Steroid hormone receptor status and prognosis in human breast cancer," in: I.Ioannidou-Mouzaka, et al (ed), Senology, Elsevier Science Publishers B.V., 241-244.